Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT ID: NCT03132194
Last Updated: 2017-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
1125 participants
INTERVENTIONAL
2016-08-08
2017-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT02929719
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT04015375
Efficacy Study in Patients With Acne Vulgaris.
NCT02935036
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
NCT02865005
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
NCT02944461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DPSG 7.5%
DPSG 7.5% (Taro Pharmaceuticals USA)
Topical, twice daily on the face for 84 days.
DPSG 7.5%
topical gel
Vehicle Gel
Placebo product (Taro Pharmaceuticals Inc.)
Topical, twice daily on the face for 84 days.
Placebo
topical gel
Aczone
dapsone 7.5
Topical, twice daily on the face for 84 days.
Aczone
topical gel
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DPSG 7.5%
topical gel
Aczone
topical gel
Placebo
topical gel
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Pharmaceutical Industries, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catawba Research
Role: STUDY_CHAIR
http://catawbaresearch.com/contact/
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DPSG-1517
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.